News

Disappointing Results in Study of Iniparib for Metastatic Triple-Negative Breast Cancer


 

Originally published by "The Pink Sheet." Internal Medicine News Digital Network and "The Pink Sheet" are owned by Elsevier.

Pages

Recommended Reading

Genomic Profile Predicts Recurrence Risk in Colorectal Cancer
MDedge Internal Medicine
PET-Detected Response to Chemo Means Better Prognosis in Esophagogastric Junction Cancer
MDedge Internal Medicine
Small Occult Metastases in Sentinel Nodes Don't Warrant Investigation
MDedge Internal Medicine
Smoking Raises Risk of Breast Cancer Modestly
MDedge Internal Medicine
In the Pipeline: Three Novel Drugs Hit Three Different Targets in CLL
MDedge Internal Medicine
Melanoma Vaccine Gets Orphan Designation
MDedge Internal Medicine
FDA Warns of Possible Link Between Breast Implants and Rare Cancer
MDedge Internal Medicine
The Oncology Report Guide to New Oncology Drugs and Indications
MDedge Internal Medicine
Bisphosphonate Use May Be Linked to Reduced Colorectal Cancer Risk
MDedge Internal Medicine
Early Analysis Supports Erlotinib for First-Line Treatment of NSCLC With EGFR Mutation
MDedge Internal Medicine